Biblio

Author Title Type [ Year(Asc)]
Filters: Author is de Fontbrune, Flore Sicre  [Clear All Filters]
2024
Frieri C, Poli A, Balsat M, de Fontbrune FSicre. The role of allogeneic stem cell transplantation in severe erythropoietic protoporphyria in adults and young adults: timing and modalities. Hematol Transfus Cell Ther. 2024.
2023
Poli A, Frieri C, Lefebvre T, Delforge J, Mirmiran A, Talbi N, Moulouel B, Six M, Paradis V, Parquet N, et al. Management of erythropoietic protoporphyria with cholestatic liver disease: A case report. Mol Genet Metab Rep. 2023;37:101018.
Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen M-D, Rivet J, Moins-Teisserenc H, Ta V-A, Ram-Wolff C, Bouaziz J-D, et al. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib. J Eur Acad Dermatol Venereol. 2023.
2021
Risitano AM, Röth A, Soret J, Frieri C, de Fontbrune FSicre, Marano L, Alashkar F, Benajiba L, Marotta S, Rozenberg I, et al. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. Lancet Haematol. 2021.
2020
Bondeelle L, Chevret S, Hurabielle C, Samy L, Goletto T, Costantini A, de Fontbrune FSicre, Michonneau D, Socié G, Tazi A, et al. Effect of Ruxolitinib on lung function after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2020.
Giannoni L, Morin F, Robin M, Peyneau M, Schlageter MHélène, Desmier D, Pagliuca S, Del Galy ASutra, de Fontbrune FSicre, Xhaard A, et al. Human-derived α1-antitrypsin is still efficacious in heavily pretreated patients with steroid-resistant gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2020.
2018
Ruggiu M, Bedossa P, Rautou PEmmanuel, Bertheau P, Plessier A, de Latour RPeffault, Robin M, de Fontbrune FSicre, Pagliuca S, Villate A, et al. Utility and safety of liver biopsy in patients with undetermined liver blood test anomalies after allogeneic hematopoietic stem cell transplantation, a monocentric retrospective cohort study. Biol Blood Marrow Transplant. 2018.
2016
Robin M, Porcher R, Wolschke C, de Fontbrune FSicre, Alchalby H, Christopeit M, Cassinat B, Zabelina T, de Latour RPeffault, Ayuk F, et al. Outcome after transplantation according to reduced intensity conditioning regimen in patients transplanted for myelofibrosis. Biol Blood Marrow Transplant. 2016.
2015
de Fontbrune FSicre, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay J-O, Neven B, Moussi J, Simon L, et al. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC. Transplantation. 2015.
2014
Meunier M, Manez A-C, Xhaard A, de Latour RPeffault, de Fontbrune FSicre, Dhedin N, Socié G, Robin M. Late Donor Bone Marrow Failure After Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation. 2014;97(12):e75-e77.